BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Intestine
,
Human chorionic gonadotropin
,
Bleomycin
,
rs2230926
,
TGFB1
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD79B
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
B lymphocyte (naive) of spleen
B lymphocyte (IgM memory) of spleen
Tonsil
Plasma cell of spleen
Myeloid cells of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Syndrome of infant of diabetic mother
Peritoneal foreign body
Systemic infection
Sepsis due to coagulase negative Staphylococcus
Sepsis due to Streptococcus agalactiae
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one
Oligodeoxyribonucleotides
Granulocyte Colony-Stimulating Factor
5-(6)-carboxyfluorescein diacetate succinimidyl ester
Butylhydroxybutylnitrosamine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PHF23
MTHFD2
PTPN6
BMPR1A
SLC35B1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Synergistic cooperation and crosstalk between MYD88L265P and mutations that dysregulate CD79B and su…
Human CD79b+ neutrophils in the blood are associated with early-stage melanoma.
B-cell inhibition by cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies i…
TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells…
An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse la…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B A…
Treatment of CD79B Mutant Relapsed/Refractory Diffuse Large B-Cell Lymphoma With Bruton Tyrosine Kin…
CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia a…
A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adu…
A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participan…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ